| Year |
Citation |
Score |
| 2006 |
De Bortoli M, Castellino RC, Lu XY, Deyo J, Sturla LM, Adesina AM, Perlaky L, Pomeroy SL, Lau CC, Man TK, Rao PH, Kim JY. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. Bmc Cancer. 6: 223. PMID 16968546 DOI: 10.1186/1471-2407-6-223 |
0.593 |
|
| 2005 |
Sturla LM, Cowan CW, Guenther L, Castellino RC, Kim JY, Pomeroy SL. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death. Cancer Research. 65: 5683-9. PMID 15994942 DOI: 10.1158/0008-5472.Can-04-2283 |
0.549 |
|
| 2004 |
Fernandez-Teijeiro A, Betensky RA, Sturla LM, Kim JY, Tamayo P, Pomeroy SL. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 994-8. PMID 14970184 DOI: 10.1200/Jco.2004.03.036 |
0.595 |
|
| 2003 |
Pomeroy SL, Sturla LM. Molecular biology of medulloblastoma therapy. Pediatric Neurosurgery. 39: 299-304. PMID 14734863 DOI: 10.1159/000075257 |
0.486 |
|
| 2003 |
Kim JY, Nelson AL, Algon SA, Graves O, Sturla LM, Goumnerova LC, Rowitch DH, Segal RA, Pomeroy SL. Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice. Developmental Biology. 263: 50-66. PMID 14568546 DOI: 10.1016/S0012-1606(03)00434-2 |
0.574 |
|
| 2003 |
Sturla LM, Fernandez-Teijeiro A, Pomeroy SL. Application of microarrays to neurological disease. Archives of Neurology. 60: 676-82. PMID 12756130 DOI: 10.1001/Archneur.60.5.676 |
0.506 |
|
| 2002 |
Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415: 436-42. PMID 11807556 DOI: 10.1038/415436A |
0.595 |
|
| Show low-probability matches. |